The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Proteome-wide covalent ligand discovery in native biological systems
Open accessAbstract
Small molecules are powerful tools for investigating protein function and can serve as leads for new therapeutics. Most human proteins, however, lack small-molecule ligands, and entire protein classes are considered 'undruggable'. Fragment-based ligand discovery can identify small-molecule probes for proteins that have proven difficult to target using high-throughput screening of complex compound libraries. Although reversibly binding ligands are commonly pursued, covalent fragments provide an alternative route to small-molecule probes, including those that can access regions of proteins that are difficult to target through binding affinity alone. Here we report a quantitative analysis of cysteine-reactive small-molecule fragments screened against thousands of proteins in human proteomes and cells. Covalent ligands were identified for >700 cysteines found in both druggable proteins and proteins deficient in chemical probes, including transcription factors, adaptor/scaffolding proteins, and uncharacterized proteins. Among the atypical ligand-protein interactions discovered were compounds that react preferentially with pro- (inactive) caspases. We used these ligands to distinguish extrinsic apoptosis pathways in human cell lines versus primary human T cells, showing that the former is largely mediated by caspase-8 while the latter depends on both caspase-8 and -10. Fragment-based covalent ligand discovery provides a greatly expanded portrait of the ligandable proteome and furnishes compounds that can illuminate protein functions in native biological systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although human CASP10 shares some degree of substrate specificity with CASP8 [317] and possibly contributes to extrinsic apoptosis in primary T cells [318]”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [318]
In the citing paper
“Covalent inhibitors have been reported to achieve high efficiency through forming covalent bonds with cysteine or other nucleophilic residues in the target protein.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [53]
In the citing paper
“Reactive cysteine residues on proteins have high nucleophilicity, which enables covalent binding with electrophilic small molecules [53, 54].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [53]
In the citing paper
“In this study, more than 700 ligandable cysteines were identified, and information was provided about the proteome-wide selectivity of each covalent fragment in the library.”
From Advances in covalent drug discovery (2022) · cites this paper as [180]
In the citing paper
“The use of competitive isoTOP-ABPP was expanded to identify proteome-wide targets of a small covalent fragment library by competing individual acrylamide and chloroacetamide fragments against an iodoacetamide–alkyne probe180.”
From Advances in covalent drug discovery (2022) · cites this paper as [180]
In the citing paper
“showing that this approach can rapidly identify compounds that target proteins of biological interest.”
From Advances in covalent drug discovery (2022) · cites this paper as [180]
In the citing paper
“The covalent ligands discovered with this approach and their corresponding ligandable sites were used to help elucidate the role of caspase 8 and caspase 10 in extrinsic apoptosis in T cells”
From Advances in covalent drug discovery (2022) · cites this paper as [180]
In the citing paper
“We finally observed limited overlap of enantioprobe targets with proteins that demonstrated ligandability in previous chemical proteomic studies using cysteine-26,27 or lysine-reactive28 electrophilic fragments (Fig. 3b)”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [26]
In the citing paper
“prior to further processing using a well-validated method for covalent ligand target identification—isotopic tandem orthogonal proteolysis ABPP (isoTOP-ABPP) 2,17,26.”
From Manumycin polyketides act as molecular glues between UBR7 and P53 (2020) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 26,294
Self-citationBLAST+: architecture and applications
Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-421 · Cited by 22,074
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M. S., James, C. A. J., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,745
The I-TASSER Suite: protein structure and function prediction
Yang, J., Yan, R., Roy, A., Xu, D., Poisson, J., & Zhang, Y. (2015) · Nature Methods · doi:10.1038/nmeth.3213 · Cited by 5,596
UniProt: a hub for protein information
The UniProt Consortium (2015) · Nucleic Acids Research · doi:10.1093/nar/gku989 · Cited by 5,106
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557
DrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou-Feunang, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,995
Cited by
Sorted by citations
Items 501–600 of 953
Quantitative proteomics and applications in covalent ligand discovery
Basu, A. A., & Zhang, X. (2024) · Frontiers in Chemical Biology · doi:10.3389/fchbi.2024.1352676 · Cited by 11
Advanced technologies for screening and identifying covalent inhibitors
Guo, Y., Wen, S., Tong, A., & Wang, Y. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.117833 · Cited by 11
Moraru, R., Valle‐Argos, B., Minton, A. R., Buermann, L. E., Pan, S., Wales, T. E., Joseph, R. E., Andreotti, A. H., Strefford, J. C., Packham, G., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01927 · Cited by 12
In Cellulo Cysteine Umpolung for Protein Structure Probing
Hartmann, P., Bohdan, K., Vogelsang, L., Marchionni, D., Preisinger, C., Vetere, A., Dietz, K., & Ritter, T. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c10259 · Cited by 11
Proteome-Wide Discovery of Degradable Proteins Using Bifunctional Molecules
Forrest, I., Conway, L. P., Gathmann, C., Jadhav, A. M., Chiu, T.-Y., Chaheine, C. M., Estrada, M. A., Shrestha, A., Sarris, K., Reitsma, J. M., et al. (2025) · ACS Central Science · doi:10.1021/acscentsci.5c01594 · Cited by 12
Synthesis and Target Identification of a Novel Electrophilic Warhead, 2-Chloromethylquinoline
Ni, F., Ekanayake, A. I., Espinosa, B., Yu, C., Sanders, J. N., Perino, J., Houk, K. N., & Zhang, C. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00359 · Cited by 11
Quantitative Chemoproteomic Methods for Reactive Cysteinome Profiling
Xiao, W., Chen, Y., & Wang, C. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200100 · Cited by 12
Laughlin, S., Carter, K., Ivanov, I. N., & Wilson, W. D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1232 · Cited by 11
Identification of Noncatalytic Lysine Residues from Allosteric Circuits via Covalent Probes
Bongard, J., Lorenz, M., Vetter, I. R., Stege, P., Porfetye, A. T., Schmitz, A. L., Kaschani, F., Wolf, A., Koch, U., Nußbaumer, P., et al. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00101 · Cited by 11
Oxidant-Induced Bioconjugation for Protein Labeling in Live Cells
Liu, Y., Liu, J.-C., Zhang, X., Guo, C., Xing, X., Zhang, Z., Ding, K., & Li, Z. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00740 · Cited by 12
Multi-omic stratification of the missense variant cysteinomePreprint
Desai, H. S., Ofori, S., Boatner, L. M., Yu, F., Villanueva, M., Ung, N., Nesvizhskii, A. I., & Backus, K. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.12.553095 · Cited by 11
Self-citationBhujbal, S. P., & Hah, J. (2023) · Pharmaceuticals · doi:10.3390/ph16091295 · Cited by 10
“In our review, we do not provide a detailed description of how each of the cysteine-reactive electrophiles reacts, as this information was already covered in a previously published article [2,47].”
InfluentialTargeting Cysteine Oxidation in Thrombotic Disorders
Yang, M., & Silverstein, R. L. (2024) · Antioxidants · doi:10.3390/antiox13010083 · Cited by 12
“As carbon nucleophiles covalently label sulfenylation, they are useful tools for probing cysteine oxidation in model systems and could be used as future backbones for drug development against oxidized thiols.”
BackgroundKim, H., Byun, D. P., Thakur, K., Ritchie, J., Xie, Y., Holewinski, R. J., Suazo, K. F., Stevens, M., Liechty, H., Tagirasa, R., et al. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00025 · Cited by 10
Póti, Á. L., Bálint, D., Alexa, A., Sok, P., Ozsváth, K., Albert, K., Turczel, G., Magyari, S., Ember, O., Papp, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52574-1 · Cited by 11
“Thus,thereisaneedtobroadenthecurrentcatalog of suitable Michael acceptors, by using chemoproteomic platforms and/or rational design 8 – 11 .”
MethodElucidating Molecular Mechanisms of Drug-Induced Hepatotoxicity of Lapatinib
Yu, Q., Ma, L., Norona, L. M., Dragovich, P. S., Wang, J., Wang, S., Chen, Y.-C., Khojasteh, S. C., Kenny, J. R., Dean, B. J., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01305 · Cited by 10
Diversity oriented clicking for modular synthesis
Wang, Z., Homer, J. A., Zegeye, E. K., Dada, L., Wolan, D. W., Kitamura, S., & Moses, J. E. (2025) · Nature Reviews Methods Primers · doi:10.1038/s43586-025-00421-y · Cited by 11
Self-citationAn Oncometabolite Isomer Rapidly Induces a Pathophysiological Protein Modification
Bergholtz, S. E., Briney, C. A., Najera, S. S., Perez, M., Linehan, W. M., & Meier, J. L. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00044 · Cited by 10
Best Practices for Design and Characterization of Covalent Chemical Probes
Gabizon, R., Resnick, E., & London, N. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160745-00069 · Cited by 10
Ma, T. P., Izrael-Tomasevic, A., Mroue, R. M., Budayeva, H. G., Malhotra, S., Raisner, R. M., Evangelista, M., Rose, C. M., Kirkpatrick, D. S., & Yu, K. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00703 · Cited by 8
Discovery of cisplatin-binding proteins by competitive cysteinome profiling
Wang, X., Zhang, Y., & Wang, C. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00042g · Cited by 12
Xiao, Z., Chen, D., Mulder, F., Song, S., van der Wouden, P. E., Cool, R. H., Melgert, B. N., Poelarends, G. J., & Dekker, F. J. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202103030 · Cited by 10
Protein Labeling and Crosslinking by Covalent Aptamers
Tivon, Y., Falcone, G. N., & Deiters, A. (2021) · Angewandte Chemie · doi:10.1002/ange.202101174 · Cited by 11
Covalent fragment mapping of KRasG12C revealed novel chemotypes with in vivo potency
Orgován, Z., Péczka, N., Petri, L., Ábrányi‐Balogh, P., Ranđelović, I., Tóth, S., Szakács, G., Nyíri, K., Vértessy, B. G., Pálfy, G., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115212 · Cited by 10
An electrophilic fragment screening for the development of small molecules targeting caspase-2
Cuellar, M. E., Yang, M., Surendra, K., Zhang, Y., Zhu, H., Sun, H., Shen, M., Hall, M. D., Patnaik, S., Ashe, K. H., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115632 · Cited by 9
Peng, Q., & Weerapana, E. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.11.010 · Cited by 9
(2024) · doi:10.1021/acscentsci.3c00822 · Cited by 9
“It has also become the gold-standard approach for profiling both on- and off-target effects of covalent drugs (52-56).”
Natural product-inspired molecules for covalent inhibition of SHP2 tyrosine phosphatase
Liang, W., Krabill, A. D., Gallagher, K. S., Muli, C. S., Qu, Z., Trader, D. J., Zhang, Z., & Dai, M. (2024) · Tetrahedron · doi:10.1016/j.tet.2024.133918 · Cited by 9
Verma, S. K., Witkin, K. L., Sharman, A., & Smith, M. A. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae075 · Cited by 10
Emerging opportunities for intact and native protein analysis using chemical proteomics
Edwards, A. N., & Hsu, K. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.343551 · Cited by 11
Size-Dependent Target Engagement of Covalent Probes
Petri, L., Gabizon, R., Ferenczy, G. G., Péczka, N., Egyed, A., Ábrányi‐Balogh, P., Takács, T., & Keserű, G. M. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00017 · Cited by 10
Proteomic Ligandability Maps of Phosphorus(V) Stereoprobes Identify Covalent TLCD1 Inhibitors
Sharma, H. A., Bielecki, M., Holm, M. A., Thompson, T. M., Yin, Y., Cravatt, J. B., Ware, T. B., Reed, A., Nassir, M., Ewing, T. E., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c01944 · Cited by 11
Self-citationBonus, M., Greb, J., Majmudar, J. D., Boehm, M., Korczynska, M., Nazemi, A., Mathiowetz, A. M., & Gohlke, H. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169196 · Cited by 12
Tan, X., Wang, D., Yao, Y., Liu, K., Chen, Y., Fu, S., & Ni, F. (2025) · PROTEOMICS · doi:10.1002/pmic.70019 · Cited by 9
“Covalent probes bearing reactive warheads that can covalently interact with a variety of amino acid residues in human proteins—not limited to cysteine—and the diversity of targeted residues is crucial for target and drug identification [14, 15].”
Chemoproteomic Profiling of Covalent XPO1 Inhibitors to Assess Target Engagement and Selectivity
Martin, J. G., Ward, J. A., Feyertag, F., Zhang, L., Couvertier, S. M., Guckian, K. M., Huber, K., & Johnson, D. S. (2021) · ChemBioChem · doi:10.1002/cbic.202100038 · Cited by 9
SDR enzymes oxidize specific lipidic alkynylcarbinols into cytotoxic protein-reactive species
Demange, P., Joly, E., Marcoux, J., Zanon, P. R. A., Listunov, D., Rullière, P., Barthes, C., Noirot, C., Izquierdo, J.-B., Rozié, A., et al. (2022) · eLife · doi:10.7554/elife.73913 · Cited by 9
High‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery
Craven, G. B., Affron, D. P., Allen, C. E., Matthies, S., Greener, J. G., Morgan, R. M. L., Tate, E. W., Armstrong, A., & Mann, D. J. (2018) · Angewandte Chemie · doi:10.1002/ange.201711825 · Cited by 10
Solid Phase Synthesis of Fluorosulfate Containing Macrocycles for Chemoproteomic Workflows
Faucher, F. F., Abegg, D., Ipock, P., Adibekian, A., Lovell, S., & Bogyo, M. S. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202300020 · Cited by 10
Heterobifunctional small molecules to modulate RNA function
Kovachka, S., Tong, Y., Childs‐Disney, J. L., & Disney, M. D. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.03.006 · Cited by 9
Das Cysteinom der Proteinkinasen als Zielstruktur in der Arzneistoffentwicklung
Chaikuad, A., Koch, P., Laufer, S., & Knapp, S. (2017) · Angewandte Chemie · doi:10.1002/ange.201707875 · Cited by 9
Let K-Ras activate its own inhibitor
Statsyuk, A. V. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0066-0 · Cited by 9
Amaral, P. A., Autheman, D., de Melo, G. D., Gouault, N., Cupif, J., Goyard, S., Dutra, P. M. L., Coatnoan, N., Cosson, A., Monet, D., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006853 · Cited by 9
“Although conventional strategies in drug design focus on competitive inhibitors, the identification of covalent inhibitors is fortunate considering the growing interest in this type of enzymatic inhibitors [19, 20].”
BackgroundVinyl sulfonamide synthesis for irreversible tethering via a novel α-selenoether protection strategy
Craven, G. B., Affron, D. P., Raymond, P. N., Mann, D. J., & Armstrong, A. (2018) · MedChemComm · doi:10.1039/c8md00566d · Cited by 10
Covalent fragment libraries in drug discovery—Design, synthesis, and screening methods
Hocking, B. J. W., Armstrong, A., & Mann, D. J. (2023) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2023.10.003 · Cited by 9
Kutikhin, A. G., Sinitsky, M. Y., Yuzhalin, A. E., & Velikanova, E. A. (2018) · Microarrays · doi:10.3390/ht7010005 · Cited by 10
The mRNA‐Binding Protein HuR Is a Kinetically‐Privileged Electrophile Sensor
Poganik, J. R., Hall‐Beauvais, A. V., Long, M. J. C., Disare, M. T., Zhao, Y., & Aye, Y. (2020) · Helvetica Chimica Acta · doi:10.1002/hlca.202000041 · Cited by 8
MS-Based in Situ Proteomics Reveals AMPylation of Host Proteins during Bacterial Infection
Rauh, T., Brameyer, S., Kielkowski, P., Jung, K., & Sieber, S. A. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00740 · Cited by 9
Rational Chemical Design of Molecular Glue DegradersPreprint
Toriki, E. S., Papatzimas, J. W., Nishikawa, K., Dovala, D., McGregor, L. M., Hesse, M. J., McKenna, J. M., Tallarico, J. A., Schirle, M., & Nomura, D. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.04.512693 · Cited by 9
Comprehensive Mapping of Electrophilic Small Molecule-Protein Interactions in Human CellsPreprint
Cravatt, B. F., Njomen, E., Hayward, R., DeMeester, K. E., Ogasawara, D., Dix, M. M., Nguyen, T., Ashby, P., Simon, G. M., Schreiber, S. L., et al. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-s446n · Cited by 9
Self-citationJulio, A. R., Shikwana, F., Truong, C. C., Burton, N. R., Dominguez, E. R., Turmon, A. C., Cao, J. X., & Backus, K. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.30.564067 · Cited by 8
Self-citationBelcher, B. P., Machicao, P. A., Tong, B., Ho, E., Friedli, J., So, B., Bui, H., Isobe, Y., Maimone, T. J., & Nomura, D. K. (2023) · ChemBioChem · doi:10.1002/cbic.202300111 · Cited by 8
Structure-based rational design of covalent probes
Holcomb, M., Llanos, M. A., Hansel-Harris, A., & Forli, S. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01606-y · Cited by 9
“A modi fi ed version of the initial reactive docking methodology 113 , WIDOCK 109 parameterizes the reward of the reactive pseudo-Lennard-Jonespotentialwitheitherexperimentaldata,suchaskineticmeasurements ofadductformationwithcysteinesurrogates,orcomputationalquantum…”
Self-citationCOOKIE-Pro: covalent inhibitor binding kinetics profiling on the proteome scale
Lin, H., Yang, B., Ding, L., Yang, Y., Holt, M. V., Jung, S. Y., Zhang, B., Wang, M. C., & Wang, J. (2025) · Nature Communications · doi:10.1038/s41467-025-63491-2 · Cited by 10
“These methodologies enable ef fi cient and systematic exploration of covalent interactions, facilitating the discovery of targets and the optimization of covalent inhibitors 7,9,43,44 .”
The covalent docking software landscape: features and applications in drug design
Singh, N., Vayer, P., & Villoutreix, B. O. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf697 · Cited by 8
“It applies the reactive docking methodology described by Backus et al [144].”
Fu, X., Liu, W., Demyanenko, Y., Kamel, W., Ravi, R. T., Ruscica, V., Noerenberg, M., Yin, X., Jiang, Y., Fan, C.-H., et al. (2026) · Nature Chemistry · doi:10.1038/s41557-025-02017-1 · Cited by 8
Labenski, M., Bateman, L. A., Voortman, L., Giammo, G., Cantin, S. M., Qiao, L., & Corin, A. F. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00422 · Cited by 8
Activity‐Based Protein Profiling of Oxidases and Reductases
Krammer, L., & Breinbauer, R. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200086 · Cited by 8
Covalent Targeting of Glutamate Cysteine Ligase to Inhibit Glutathione Synthesis**
Zhang, L. H., Tang, M., Tao, X. B., Shao, Q., Thomas, V., Shimizu, S., Kasano, M., Ishikawa, Y., Inukai, T., & Nomura, D. K. (2023) · ChemBioChem · doi:10.1002/cbic.202300371 · Cited by 11
Automation to Enable High-Throughput Chemical Proteomics
Lin, Z., Gongora, J. M., Liu, X., Xie, Y., Zhao, C., Lv, D., & Garcia, B. A. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00467 · Cited by 9
Graph neural networks for identifying protein-reactive compounds
Gil, V., & Rowley, C. N. (2024) · Digital Discovery · doi:10.1039/d4dd00038b · Cited by 7
Global Profiling Lysine Reactivity and Ligandability with Oxidant‐Triggered Bioconjugation Chemistry
Zhou, M., Li, S., Tan, Y., Huang, W., Li, Y.-F., Yuan, X., & Li, Z. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202418473 · Cited by 9
STEFs: Activated Vinylogous Protein‐Reactive Electrophiles
Hansen, B. K., Loveridge, C. J., Thyssen, S., Wørmer, G. J., Nielsen, A. D., Palmfeldt, J., Johannsen, M., & Poulsen, T. B. (2019) · Angewandte Chemie · doi:10.1002/ange.201814073 · Cited by 8
Analysis of the ERK Pathway Cysteinome for Targeted Covalent Inhibition of RAF and MEK Kinases
Romany, A., Liu, R., Zhan, S., Clayton, J., & Shen, J. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00014 · Cited by 8
G– PLIP : Knowledge graph neural network for structure-free protein–ligand bioactivity prediction
Crouzet, S., Lieberherr, A. M., Atz, K., Nilsson, T., Sach-Peltason, L., Müller, A. T., Peraro, M. D., & Zhang, J. D. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.06.029 · Cited by 9
A Chemoproteomic Platform To Assess Bioactivation Potential of Drugs
Sun, R., Shi, F., Liu, K., Fu, L., Tian, C., Yang, Y., Tallman, K. A., Porter, N. A., & Yang, J. H. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.7b00183 · Cited by 8
Nuclear Receptor Chemical Reporter Enables Domain-Specific Analysis of Ligands in Mammalian Cells
Tsukidate, T., Li, Q., & Hang, H. C. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00432 · Cited by 8
Chemical proteomic identification of functional cysteines with atypical electrophile reactivities
Litwin, K. M., Crowley, V. M., Suciu, R. M., Boger, D. L., & Cravatt, B. F. (2021) · Tetrahedron Letters · doi:10.1016/j.tetlet.2021.152861 · Cited by 9
Self-citationBinding Mode Prediction and Virtual Screening Applications by Covalent Docking
Scarpino, A., Ferenczy, G. G., & Keserű, G. M. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1209-5_4 · Cited by 9
McEnaney, P. J., Balzarini, M., Park, H., & Kodadek, T. J. (2020) · Chemical Communications · doi:10.1039/d0cc02588g · Cited by 8
Dubiella, C., Pinch, B. J., Zaidman, D., Manz, T. D., Poon, E., He, S., Resnick, E., Langer, E. M., Daniel, C. J., Seo, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.20.998443 · Cited by 8
Profiling the Proteome-Wide Selectivity of Diverse ElectrophilesPreprint
Zanon, P. R. A., Yu, F., Musacchio, P. Z., Lewald, L., Zollo, M., Krauskopf, K., Mrdović, D., Raunft, P., Maher, T. E., Cigler, M., et al. (2021) · ChemRxiv · doi:10.26434/chemrxiv.14186561 · Cited by 10
Targeted Protein Degradation through Recruitment of the CUL4A Complex Adaptor Protein DDB1Preprint
Meyers, M., Cismoski, S., Panidapu, A., Chie-Leon, B., & Nomura, D. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.11.553046 · Cited by 8
Tuning isatoic anhydrides’ lysine ligation chemistry for bioconjugation and drug delivery
Tiwari, S., Senthil, S., Khanna, S., Duraisamy, S., Vechalapu, S. K., Mallojjala, S. C., & Allimuthu, D. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.102260 · Cited by 7
Burgoyne, J. R., & Eaton, P. (2025) · Physiological Reviews · doi:10.1152/physrev.00051.2024 · Cited by 10
Peptide-Based Targeted Covalent Inhibitors
Cao, F., Guo, R.-C., Zhang, Z., & Yu, Z. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c18100 · Cited by 8
Feng, Y., Zeng, S., Xu, F., Huang, W., Li, S., Tan, Y., & Li, Z. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c17457 · Cited by 8
Zhou, Y., Zhang, L., Niu, Z. L., & Wang, Z. A. (2025) · Biomolecules · doi:10.3390/biom15121699 · Cited by 9
“Warheads are particularly valuable due to their intrinsic electrophilicity, which allows them to covalently target nucleophilic residues such as Cys, Lys, and His [24,25].”
Kim, J., Correy, G. J., Hall, B. W., Rachman, M. M., Mailhot, O., Togo, T., Gonciarz, R. L., Jaishankar, P., Neitz, R. J., Hantz, E. R., et al. (2026) · eLife · doi:10.64898/2025.12.25.696505 · Cited by 15
“Two attractive applications are the prediction of ligand-bound complexes, around which structure-based ligand design is articulated (Erlanson et al. 2025); (Backus et al. 2016), and the re-scoring of large library docking hit-lists.”
Complexoform-restricted covalent TRMT112 ligands that allosterically agonize METTL5
Goetzke, F. W., Bernard, S. M., Ju, C., Pollock, J., DeMeester, K. E., Gross, J., Simon, G. M., He, C., Melillo, B. N., & Cravatt, B. F. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02099-5 · Cited by 8
“Each pair of enantiomeric BcpAc stereoprobes was synthesized in non-alkyne (FWG-1A ( 9 ), FWG-1B ( 10 ), FWG-2A ( 11 ) and FWG-2B ( 12 )) and alkyne (FWG-3A ( 13 ), FWG-3B ( 14 ), FWG-4A ( 15 ) and FWG-4B ( 16 )) form (Fig.”
Self-citationModular Vinyl Phosphonamidates for Cysteine-Directed Protein Targeting
Stieger, C. E., Völkel, C., Bertelsen, M. B., Lisurek, M., Arafiles, J. V. V., Franke, J., Crocker, L. B., Schuppe, K. T., Lim, Y., Groneberg, C., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c22349 · Cited by 8
Small molecule inhibitors for cancer metabolism: promising prospects to be explored
Liu, D., Wang, H., Li, X., Liu, J., Zhang, Y., & Hu, J. Y. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04501-4 · Cited by 7
Rodrigues, S. B. D. F., de Araújo, R. S. A., de Mendonça, T. R. D., Mendonça, F. J. B., Zhan, P., & da Silva‐Júnior, E. F. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815179934123010010 · Cited by 8
Jia, Y., Oyken, M., Kim, R. Q., Tjokrodirijo, R. T. N., de Ru, A. H., Janssen, A. P. A., Hacker, S. M., van Veelen, P. A., Geurink, P. P., & Sapmaz, A. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02410 · Cited by 7
Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2
Patel, D. K., Kumar, H., & Sobhia, M. E. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108132 · Cited by 7
Isocyanides inhibit bacterial pathogens by covalent targeting of essential metabolic enzymes
Geißler, A., Junca, H., Kany, A. M., Daumann, L. J., Hirsch, A. K. H., Pieper, D. H., & Sieber, S. A. (2024) · Chemical Science · doi:10.1039/d4sc01940g · Cited by 7
Targeting a Pathogenic Cysteine Mutation: Discovery of a Specific Inhibitor of Y279C SHP2
Kim, J., Plaman, B. A., & Bishop, A. C. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00471 · Cited by 7
Targeted Covalent Inhibitors for the Treatment of Malaria?
Kulkarni, S., Urbahns, K., & Spangenberg, T. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00684 · Cited by 6
Measuring and predicting warhead and residue reactivity
Awoonor‐Williams, E., Kennedy, J., & Rowley, C. N. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.09.001 · Cited by 8
Liu, X., & Ciulli, A. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-00978-9 · Cited by 7
Cornejo, N. R., Amofah, B., Lipinski, A. A., Langlais, P. R., Ghosh, I., & Jewett, J. C. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00820 · Cited by 7
Stable Pyrrole‐Linked Bioconjugates through Tetrazine‐Triggered Azanorbornadiene Fragmentation
de Montes, E. G., Istrate, A., Navo, C. D., Jiménez‐Moreno, E., Hoyt, E. A., Corzana, F., Robina, I., Jiménez‐Osés, G., Moreno‐Vargas, A. J., & Bernardes, G. J. L. (2020) · Angewandte Chemie · doi:10.1002/ange.201914529 · Cited by 7
Cheng, X., Wang, N., Jiang, Z., Chen, Z., Niu, Y., Tong, L., Yu, T., & Tang, B. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00080 · Cited by 7
Conditional Covalent Lethality Driven by Oncometabolite Accumulation
Perez, M., Nance, K. D., Bak, D. W., Gamage, S. T., Najera, S. S., Conte, A. N., Linehan, W. M., Weerapana, E., & Meier, J. L. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00384 · Cited by 6
Profiling protein targets of cellular toxicant exposure
Genereux, J. C. (2023) · Molecular Omics · doi:10.1039/d2mo00246a · Cited by 8
Current status and future prospects for enabling chemistry technology in the drug discovery process
Djurić, S. W., Hutchins, C. W., & Talaty, N. N. (2016) · F1000Research · doi:10.12688/f1000research.9515.1 · Cited by 7
Expanding chemogenomic space using chemoproteomics
Jones, L. H. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.06.022 · Cited by 7
Electrophilic Screening Platforms for Identifying Novel Covalent Ligands for E3 Ligases
Zheng, S., & Crews, C. M. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00301 · Cited by 7
Selective Inhibition of Cysteine-Dependent Enzymes by Bioorthogonal Tethering
Spear, L. A., Huang, Y., Chen, J., Nödling, A. R., Virdee, S., & Tsai, Y. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167524 · Cited by 7
“24 Specifically, conjugates 3 and 4 contain a weakly thiol-reactive Michael acceptor.”
BackgroundCrystal structure of human 17beta-HSD type 1 in ternary complex with PBRM and NADP+
Li, T., & Lin, S. X. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6cge/pdb · Cited by 7
Exploiting the DCAF16–SPIN4 interaction to identify DCAF16 ligands for PROTAC development
Riha, I. A., Campos, M. A. L., Jin, X., Wang, F. Y., Zhang, C., Dunne, S. F., Cravatt, B. F., & Zhang, X. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00681j · Cited by 9
“29,30 These cysteines exhibit increased nucleophilicity towards electrophiles and are frequently identified as off-target sites.”
InfluentialSelf-citation
Metadata
- Authors
- Backus, K. M., Correia, B. E., Lum, K. M., Forli, S., Horning, B. D., González-Páez, G. E., Chatterjee, S., Lanning, B. R., Teijaro, J. R., Olson, A. J., Wolan, D. W., & Cravatt, B. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Backus, Keriann M.
- Cravatt, Benjamin F.
- ORCID
- Venue
- Nature
- Published
- 2016-06-15
- Volume
- 534
- Issue
- 7608
- Pages
- 570-574
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4919207
- OpenAlex
- W2430132928
- Cited by
- 940
- References
- 43
- Citations by year
- 2026: 109 · 2025: 114 · 2024: 114 · 2023: 134 · 2022: 82 · 2021: 94 · 2020: 87 · 2019: 69 · 2018: 61 · 2017: 54 · 2016: 18
- FWCI
- 31.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (CA-087660, R37CA087660, R01CA087660)
- National Institute of General Medical Sciences (GM069832, GM-090294, GM108208, R01GM090294, F32GM108208, R01GM069832)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- covalent ligands, chemical probes, undruggable proteins, transcription factors, caspase-8, caspase-10, extrinsic apoptotic pathway, T cells, protein function
- MeSH terms
- Cells, Cultured, Cysteine, Drug Evaluation, Preclinical, Enzyme Precursors, Humans, Ligands, Peptide Fragments, T-Lymphocytes, Transcription Factors, Apoptosis, Proteome, Caspase 8, Caspase 10, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
